Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

1983studies shown

Showing 589-600 of 1,983

Other study type icon

RecruitingISRCTN75536830

Do mentalisation-based interventions work for people with borderline personality disorder and chronic depression?

This study is recruiting. It focuses on depression and currently lists participation information in Germany.

In Germany

DepressionOtherOver 18 Years

Countries: Germany
Sponsor: Lotte Köhler Foundation (Lotte Köhler Stiftung) (Germany)
Condition: Depression

Behavioral study icon

RecruitingISRCTN64408867

Does exposure to body odors increase the effect of mindfulness treatment in people with depressive and social anxiety symptoms?

This study is recruiting in Italy. It focuses on depression.

In Italy

Anxiety, DepressionOtherOver 18 Years

Countries: Italy
Sponsor: Karolinska Institute
Condition: Anxiety, Depression

Other study type icon

RecruitingISRCTN46437760

Effectiveness of health care delivery to depressed elderly medical in Depression

This study is recruiting in the United Kingdom. It is testing health care delivery to depressed elderly medical for Depression.

In United Kingdom

Depression, AnxietyOther

Countries: United Kingdom
Sponsor: NHS R&D Regional Programme Register - Department of Health (UK)
Condition: Depression, Anxiety

Other study type icon

RecruitingNCT07136714

Does Semaglutide Improve Depressive Symptoms in people with Major Depressive Disorder and Overweight or Obesity

This study is recruiting. It focuses on depression and currently lists participation information in Denmark.

In Hillerød

DepressionOtherFrom 18 Years to 65 Years

Countries: Denmark
Sponsor: Nordsjaellands Hospital
Condition: Depression

Other study type icon

RecruitingNCT05909267

Dopamine Modulation of Motivation and Motor Function in Major Depression & Inflammation

This study is recruiting. It focuses on depression and currently lists participation information in Germany.

In Steglitz

DepressionOtherFrom 18 Years to 65 Years

Countries: Germany
Sponsor: Charite University, Berlin, Germany
Condition: Depression

Drug study icon

RecruitingNCT06075771

Dopaminergic Therapy for Anhedonia - 2

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

In Atlanta

DepressionDrugFrom 25 Years to 55 Years

Countries: United States
Sponsor: Emory University
Condition: Depression

Drug study icon

RecruitingISRCTN44111488

Dose Escalation Legitimate? Pharmacology and Imaging studies in depression

This study is recruiting. It focuses on depression and currently lists participation information in the Netherlands.

In Netherlands

DepressionOtherOver 18 Years

Countries: Netherlands
Sponsor: Academic Medical Centre (AMC) (Netherlands)
Condition: Depression

Drug study icon

RecruitingNCT06828887

LV232 Capsules for Depression

This study is recruiting in China. It is testing LV232 Capsules for Depression.

In Shanghai

DepressionDrugFrom 18 Years to 65 Years

Countries: China
Sponsor: Vigonvita Life Sciences
Condition: Depression

Behavioral study icon

RecruitingNCT06378450

Dose-Response Effects of Mindfulness Meditation

This study is recruiting. It focuses on depression and currently lists participation information in Australia.

In Carlton

DepressionBehavioralFrom 18 Years to 65 Years

Countries: Australia
Sponsor: University of Melbourne
Condition: Depression

Device study icon

RecruitingNCT05553353

Dosing rTMS for Depression Post-SCI

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

In Charleston

DepressionDeviceFrom 18 Years to 60 Years

Countries: United States
Sponsor: VA Office of Research and Development
Condition: Depression

Other study type icon

RecruitingNCT07226661

Study in Adults With Major Depressive Disorder

This study is recruiting in the United States. It focuses on depression.

In Garden Grove

DepressionOtherFrom 18 Years to 70 Years

Countries: United States
Sponsor: Supernus Pharmaceuticals, Inc.
Condition: Depression

Other study type icon

RecruitingISRCTN69617477

Study of eicosapentaenoic acid in the treatment of mood disorders among middle-aged women

This study is recruiting in Canada. It focuses on Depression.

In Canada

DepressionOther

Countries: Canada
Sponsor: Foundation Lucie et André Chagnon (Canada)
Condition: Depression

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.